Navigation Links
Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL

g/week) and LDL-C (67 mg/dL at 400 mg/week versus 76 mg/dL at 300 mg/week) than the 300 mg/week cohort.


    Table 1:  ISIS 301012 Coadministered with Statins, Summary of Results.

    Median % changes from baseline at primary endpoint*


    Per Protocol            Placebo    30 mg/week      100 mg/week

    # of patients            13        8                 8

    ApoB                     -1%       0% (p=0.80)     -20% (p=0.03)

    LDL-C                    -4%       4% (p=0.31)     -22% (p=0.01)

    VLDL-C                    7%       8% (p=0.84)      10% (p=0.66)

    Non-HDL-C                -1%       8% (p=0.44)     -20% (p=0.02)

    HDL-C                     9%       1% (p=0.24)      -4% (p=0.15)

    ApoA-1                    0%       0% (p=0.59)      -6% (p=0.66)

    TC                        2%       5% (p=0.72)     -15% (p=0.005)

    TG                        0%       4% (p=0.60)       4% (p=0.52)

    ApoB:ApoA-1              -1%       0% (p=0.97)     -15% (p=0.01)

    TC:HDL-C                 -6%       0% (p=0.27)     -15% (p=0.36)



    Per Protocol      200 mg/week     300 mg/week        400 mg/week

    # of patients    16               8                    8

    ApoB            -24% (p=0.004)  -52% (p < 0.0001)    -51% (p=0.0004)

    LDL-C           -30% (p=0.002)  -51% (p < 0.0001)    -47% (p=0.008)

    VLDL-C          -25% (p=0.38)   -63% (p = 0.08)      -69% (p=0.02)

    Non-HDL-C       -22% (p=0.02)   -51% (p < 0.0001)    -49% (p=0.008)

    HDL-C             6% (p=0.23)     5% (p = 0.41)        6% (p=0.60)

    ApoA-1            1% (p=0.93)     2% (p = 0.67)       -6% (p=0.43)

    TC              -13% (p=0.009)  -42% (p < 0.0001)    -34% (p=0.0001)

    TG              -25% (p=0.38)   -41% (p = 0.04)      -35% (p=0.02)

    ApoB:ApoA-1     -28% (p=0.006)  -55% (p < 0.0001)    -45% (p=0.0008)

    TC:HDL-C        -14% (p=0.06)   -41% (p < 0.0001)    -38% (p=0.01)


    p value = vs. placebo

    *Primary endpoint analysis w
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:4/24/2015)... -- Today, humanity takes a massive step toward reaching our ... 1-800 CONTACTS announces their new Apple Watch app which allows ... Two taps. New contacts. From your watch. We ... features LensGauge which helps keep track of how long your ... "Since our inception, we,ve been dedicated to providing ...
(Date:4/24/2015)... 2015  A new study shows an "alarming rise" over ... to slow the progression of multiple sclerosis or reduce the ... at Oregon Health & Science University (OHSU) and Oregon State ... of MS drugs in the marketplace over the past 20 ... for patients who use those drugs. Researchers found the costs ...
(Date:4/24/2015)... April 24, 2015  Span-America Medical Systems, Inc. ... its fiscal 2015 second quarter results on Thursday, April ... The company will conduct a conference call ... to review the company,s financial and operating results for ... broadcast of the conference call will be available ...
Breaking Medicine Technology:Attention: We live in the future. Order contact lenses from your wrist with the 1-800 CONTACTS app for Apple Watch 2Researchers find alarming rise in cost of MS drugs over past two decades 2Researchers find alarming rise in cost of MS drugs over past two decades 3Researchers find alarming rise in cost of MS drugs over past two decades 4
(Date:4/24/2015)... 24, 2015 With years of experience ... is now proud to be partnered with a veterinary ... animals a year. This partnership has brought new payment ... , After providing an in-house payment plan for ... Hospital (VMTH) wanted to increase financing options available to ...
(Date:4/24/2015)... 2015 IntelliSoft Group, LLC, a ... contract management software, featured IntelliCred Version 14.2 during ... Annual Educational Conference (IAMSS) on April 23-24 ... Brook, Illinois. , Notable improvements available in IntelliSoft’s ... , Contract Linking: A new Contract Connection ...
(Date:4/24/2015)... Telematics Berlin is the foremost Automotive ... & 2 suppliers, content providers, associations and government bodies. ... value chain, see them converge in Berlin. This year’s ... from those companies currently at the forefront of Europe’s ... on customer centric products, ParkTAG are one of the ...
(Date:4/24/2015)... Yisrayl Hawkins, Pastor and Overseer at The House of ... forces are used worldwide, and how they would not be ... says that the nations have been trained to build up ... to the confusion and distrust. , “The nations believe ... forced compliance, unjust rules and laws, and the rape of ...
(Date:4/24/2015)... 2015 Recent research by the CareerBuilder ... therapists and their assistants are among the top 10 ... by the year 2023. , Physical therapists are ... growth and greatest potential for expansion in the future. ... that while physical therapists can offer great relief to ...
Breaking Medicine News(10 mins):Health News:University of Missouri Veterinary Medical Teaching Hospital Teams with UGA 2Health News:IntelliSoft Group Version 14.2 of IntelliCred featured at the Illinois Association of Medical Staff Services Annual Educational Conference 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 3Health News:Armed Forces Would Not Be Necessary if Biblical Laws Were Followed, Says Yisrayl Hawkins in New Article 2Health News:Huntsville Medical Doctor Explains Why Physical Therapy May Not Treat Muscle Numbness Adequately 2
... Surayud Chulanont, has defended his government's move to allow the ... of US worries over intellectual property rights in the kingdom. ... we can explain our action to other countries as well ... This Tuesday, Health Minister Mongkol Na Songkhla will be traveling ...
... old man that visits a doc, there is a woman; much like ... for success. ,Some Older men need to be goaded ... has revealed The woman could be a wife, daughter or even a ... of men above 50 years visit a doctor only after being coaxed ...
... is not funny. Infact their love for the spirits has ... by the fallout of the binge drinking culture on the ... trend evident among all age groups, class, boundaries and cultural ... Australia in the next 20 years. Many Australians will be ...
... over a long period of time may decrease brain volume, ... Academy of Neurology's 59th Annual Meeting in Boston, April ... MRI scans of 1,839 people from the Framingham Offspring study, ... drinkers, low drinkers (one to seven drinks per week), moderate ...
... cells that can repair the most severe damage to the ... lie around and do nothing, but when neighboring cells ... A report on the discovery will appear online next week ... cells act like the Army Reserves of our nose, explains ...
... of Rhode Island have demonstrated a new way to target ... protein that acts like a nanosyringe to deliver tags or ... of the National Academy of Sciences. ... (Low) Insertion Peptide) can be injected into the abdomen of ...
Cached Medicine News:Health News:Thailand Unfazed As US Worries Over Copyright Violations 2Health News:Drinking Heavy Amounts of Alcohol Shrinks Your Brain 2Health News:When Smell Cells Fail They Call In Stem Cell Reserves 2Health News:Novel Technology to Locate and Treat Tumors 2
... Sepramesh Biosurgical Composite is designed for ... of a PPM mesh that has two ... mesh is coated with a layer of ... Biosurgery's Seprafilm® Adhesion Barrier). This coated side ...
... As Bard, The Hernia Repair Company, ... you may desire limited fibrous tissue in-growth ... as compared to polypropylene mesh. Like all ... prostheses, Reconix Patch produces a clinically proven, ...
... MYCROMESH® PLUS Biomaterial is the first ... for controlling potential operative contamination of ... contains two antimicrobial preservative agents, silver ... to inhibit bacterial colonization on the ...
... its introduction in 1958, Bard mesh has ... products are compared. Bard mesh was used ... developed the "tension-free" hernia repair many years ... safe and ideal" substance for permanent reinforcement ...
Medicine Products: